Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00327769

Completed

Faslodex Advanced Breast Cancer Local Chinese Study

Advanced Breast Cancer
NCT00171847

Terminated

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer (eLEcTRA)

Metastatic Breast Cancer
NCT00191269

Completed

Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen

Metastatic Breast Cancer
NCT07601620

Not yet recruiting

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer

HER2 + Breast Cancer
NCT07541079

Not yet recruiting

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

Early Breast Cancer
NCT07540520

Not yet recruiting

A Real-World Study on the Impact of Different Adjuvant Treatment Regimens on Prognosis in Non-pCR Patients With HER2-Positive Breast Cancer After Neoadjuvant Therapy

Early Breast Cancer
NCT07524855

Recruiting

A Study of HLD-0117 in Patients With Metastatic Breast Cancer (HLD-0117)

Metastatic Breast Cancer
NCT07519200

Not yet recruiting

Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention (SHARE-MC)

Metastatic Breast Cancer
NCT07309887

Not yet recruiting

This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer. (PRIORITY)

Early Breast Cancer
NCT07203378

Recruiting

Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu (ENERGIZE)

Metastatic Breast Cancer
NCT07187726

Recruiting

Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted Risk (PRE-ACT-01)

Unilateral Breast Neoplasms
NCT07165756

Recruiting

"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents. (MaVie)

Localized Breast Cancer
NCT07545434

Completed

The Prognostic Role of TILs and CD8+ T Cells in Operable Breast Cancer (Ν/Α)

Early Breast Cancer
NCT07275463

Enrolling by invitation

[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

Primary Breast Cancer
NCT07151963

Enrolling by invitation

Effects of Prolonged Continuous Theta Burst Stimulation in Chemotherapy-induced Peripheral Neuropathy (CIPN)

Breast Cancer Females
NCT06044623

Recruiting

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients (IMPORTANT)

Quality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older Patients
NCT02476786

Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Breast Cancer | Breast Neoplasms | Cancer of Breast | Cancer of the Breast
NCT03633331

Completed

Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

HER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7
NCT02456857

Completed

Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

Invasive Breast Carcinoma | Triple-Negative Breast Carcinoma
NCT02751710

Completed

Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer (PET ABC)

Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4) | Stage IIb Breast Cancer (T3N0)
NCT03809988

Completed

PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) (PALMIRA)

Breast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
NCT02282345

Completed

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

Invasive Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation
NCT02226276

Active, not recruiting

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Bone Metastases | Lung Metastases | HER2-positive Breast Cancer | Liver Metastases | Stage IV Breast Cancer | Recurrent Breast Cancer | Soft Tissue Metastases
NCT06766708

Completed

The Effect of a Self-Management Lymphedema Education Program on Lymphedema, Symptoms, Compliance, Daily Living Activities, and Patient Activation in Breast Cancer-Related Lymphedema: A Quasi-Experimental Study

Lymphedema | Breast Cancer Survivor
NCT04582565

Completed

Manual Lymphatic Drainage Versus Standard Treatment for the Prevention of Breast Cancer-related Lymphoedema in Patients Who Undergo Axillary Node Clearance (BCRL)

Breast Cancer Related Lymphoedema
NCT02670109

Unknown

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Triple-Negative Invasive Breast Carcinoma | Residual Tumor
NCT07579117

Recruiting

Endoscopic Video-Assisted Nipple-Sparing Mastectomy (EVA)

Breast Surgery | Breast Cancer | Endoscopic Video-assisted Nipple-sparing Mastectomy
NCT07389200

Not yet recruiting

Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer

Breast Cancer | Breast Cancer With Low to Intermediate HER2 Expression
NCT07348744

Not yet recruiting

The Effect of a Health Belief Model-Based Education Program on Breast Self-Examination Practice Behavior, Breast Cancer Fear, and Awareness Levels in Women: A Randomized Controlled Trial (KAU-BSE-RCT)

Breast Cancer | Breast Self-Examination
NCT07132242

Not yet recruiting

SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer

Metastatic Breast Cancer With HER2 Positive
NCT07084558

Recruiting

ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness (TEODOR)

Early and Locally Advanced Breast Cancer
NCT06934239

Recruiting

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients (PRISM)

Breast Cancer Screening | Artificial Intelligence (AI)
NCT06906601

Recruiting

Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study. (MAGNETO)

Breast Cancer | Breast Cancer Surgery | Medico-economic Impact
NCT06788197

Not yet recruiting

A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients

Breast Cancer | Locally Advanced or Metastatic Breast Cancer
NCT06705127

Recruiting

Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.

HR-positive,HER2-negative Breast Cancer
NCT06692725

Recruiting

De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC (NacTNBC)

Triple Negative Breast Cancer
NCT06680921

Recruiting

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

Locally Advanced or Metastatic Breast Cancer
NCT06679036

Recruiting

A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

Advanced Unresectable or Metastatic Breast Cancer
NCT06492447

Not yet recruiting

Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer

HER 2 Low-expressing Breast Cancer
NCT06025604

Recruiting

ACTIVPROSEIN : Professional Activity After Breast Cancer

Breast Cancer Female | Return to Work
NCT05906407

Recruiting

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer (COGNITION)

Neoadjuvant Therapy | Early-Stage Breast Cancer
NCT05808582

Not yet recruiting

Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer

Hormone Receptor-positive Advanced Breast Cancer
NCT05806047

Not yet recruiting

Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy

Hormone Receptor-positive Advanced Breast Cancer
NCT05749016

Recruiting

Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer

Chemotherapy Effect | Locally Advanced Breast Cancer
NCT05640778

Recruiting

Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)

Luminal B/HER2-negative Breast Cancer
NCT05430399

Recruiting

Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer
NCT05377047

Recruiting

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer (TAORMINA)

Breast Cancer Stage IV | Oligometastatic Disease
NCT05268224

Recruiting

A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue

Breast Cancer Screening
NCT05189067

Recruiting

Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer

HER2-positive Breast Cancer | Adjuvant Therapy
NCT04942899

Not yet recruiting

Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer

Metastasis Breast

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations